Navigation Links
Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
Date:12/10/2007

eated AML stem cells. The overall survival of treated engrafted mice was significantly improved with the median survival of control group 11.5 weeks versus 24 weeks for the antibody-treated group.

Secondly, 7G3 was administered to mice with established AML. Administration of the antibody to these mice reduced AML dissemination around the body of the mice. The ability of leukemic stem cells from mice treated in this way to reestablish leukemia as secondary transplants into other animals was markedly reduced.

In contrast, exposure to 7G3 had little effect on normal human bone marrow stem cells.

"These results show that 7G3 is able to target LSC's to prevent them from moving around and proliferating in the mice, while at the same time having little effect on normal blood cells," said Dr Lock at the ASH meeting today.

"This is a very exciting finding because it is one of the first drugs that has been designed to specifically target the LSC, rather than simply attacking the cancer cells proliferating in the blood and bone marrow. Hopefully this means that it can fight leukemia without many of the side effects of current drugs. It opens up an exciting new option for the treatment of AML," he said.

CSL wishes to acknowledge the contribution of the University Health Network in Toronto, Canada, The Institute of Medical and Veterinary Science/Hanson Institute for Cancer Research in South Australia, Children's Cancer Institute Australia for Medical Research in Sydney, Australia and the Queensland Institute for Medical Research, Australia, its key collaborators in this important project.

For further information please contact:

Associate Professor Richard Lock

Head, Leukaemia Biology Program

Children's Cancer Institute Australia for Medical Research

Phone: +61 414 769 194

Dr. Darryl Maher

Medical Director

CSL Bioplasma

Phone: +61 412 346 987

Media Contact

Sheila A. Burk
'/>"/>

SOURCE CSL Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
11. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  TissueGene, Inc. a clinical-stage biopharmaceutical ... the field of cell therapy, today announced the ... of Chief Operating Officer.  Mr. Newman was most ... Clinical Operations at ZIOPHARM Oncology, a ... gene expression, control and cell technologies in the ...
(Date:4/21/2015)... and PARIS and BURLINGTON, N.C. , ... (NYSE: DGX ), the world,s leading provider ... National Institute of Health and Medical Research institution, ... they co-founded to provide scientists and laboratory organizations ... and BRCA2 genetic data. The program,s goal is ...
(Date:4/21/2015)... April 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", ... marketer of medical devices worldwide, today announced that it ... ended Mar 31, 2015 after the U.S. market closes ... earnings conference call at 8:00 AM on May 12, ... 2015 Beijing/Hong Kong Time). Dial-in details ...
Breaking Medicine Technology:TissueGene, Inc. Hires Robert Newman as Chief Operating Officer 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 3Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 5Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 6Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 7Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2
... May 9 Osteoarthritis is a,painful and ... people in the United States. It is ... The novel investigational pain medication,tapentadol, a centrally ... with joint-disease pain, compared to those treated ...
... Biosciences, Inc.,(Nasdaq: RDEA ), a company focused ... for the treatment of HIV, cancer and,inflammatory diseases, ... been appointed Senior Vice President, Finance and Operations ... will resign from our board of,directors shortly thereafter. ...
Cached Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6
(Date:4/21/2015)... 2015 According to a recent article ... Gov. Wolf has made naloxone available for anyone to ... from a pharmacy without a doctor’s order- in an ... drug addiction. Pennsylvania’s state police will also begin carrying ... in Narcan) is an opiate overdose reversal medication. The ...
(Date:4/21/2015)... Lake City, Utah (PRWEB) April 21, 2015 ... reimbursement for small businesses, announced today the publication of ... , Recent health reform brought changes to the health ... changes caused some business owners to question what is ... use eBook helps small business owners determine which HRAs ...
(Date:4/21/2015)... Carinsuranceshoppingsource.com has released a new blog ... for ecological vehicles. , Eco-friendly cars can ... safer driving experience. Some insurance agencies may even offer ... a new vehicle, clients should consider the costs of ... car will always cost more to insure. Eco-friendly vehicles ...
(Date:4/21/2015)... Quark Software Inc. has introduced ... solution that enables large enterprises to streamline the ... With Quark Procedure Management, corporate writers and subject ... to save, search and update, which is critical ... issues. Examples of policies and procedures include employee ...
(Date:4/21/2015)... A new study at a British hospital shows ... like mesothelioma increased by 20 percent over a 20 ... of the study. Click here to read the ... Hospital in Basingstoke performed a retrospective analysis of outcomes ... between 1994 and 2014. They found that patients ...
Breaking Medicine News(10 mins):Health News:Drug Rehab Philadelphia Comments on Gov. Wolf’s Decision to Make Naloxone Widely Available 2Health News:Auto Insurance Quotes For Eco-Friendly Vehicles 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2
... N.C., Nov. 24 In January, victorious,politicians will go ... and health care, but patients don,t have to wait ... care. Instead, they should give,feedback directly to their doctors, ... "We don,t know whether ...
... LOS ANGELES, Nov. 24 To everyone around her, ... acting career, a successful clothing,line that was attracting international ... that for years, Melissa suffered from severe,breathing problems, extreme ... cause. , After ...
... easier, Fresho.com becomes a job search engine with the functionality of a ... ... Due to the current economic woes, employment sites are experiencing an increase ... increasing demand for new job openings, Fresho has changed its business concept ...
... A new study found that adolescents were at the greatest ... early age and the parents, smoking quickly reached high levels ... the November issue of Health Psychology , draws from ... research that suggests smoking behavior is influenced by both genetics ...
... ultrasound waves for deep vein thrombosis (DVT) may help dissolve ... according to researchers at Emory University. The study will be ... New York City. , "These clots are a main cause ... you can eliminate them the better," says Karthikeshwar Kasirajan, MD, ...
... its kind, researchers at the Yerkes National Primate ... have developed a multidisciplinary approach involving immunology, genomics ... vaccine without exposing individuals to infection. This approach ... vaccines--that of only being able to determine immunity ...
Cached Medicine News:Health News:Politicians May Not Listen ... But Doctors Do, Says DrScore 2Health News:Do You Have Genetic COPD? 2Health News:Fresho.com Adapts As The Online Recruiting Market Heats Up 2Health News:Smoking, teens and their parents: New research 2Health News:Ultrasound waves aid in rapid treatment of DVT 2Health News:Researchers discover strategy for predicting the immunity of vaccines 2
Used for vascular and non-vascular applications. Tapered fixed core construction provides gradual transition to a flexible,tip. Supplied sterile in peel-open packages. Intended for one-time use....
... Merit Medical is pleased to offer ... The pre-coated, high-performance, InQwire guide wire ... is very lubricious and can help ... available in a wide range of ...
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
Stent delivery with extra rail support...
Medicine Products: